In vivo enhancement of NK-cell activity by thymopentin

Int J Immunopharmacol. 1990;12(2):193-7. doi: 10.1016/0192-0561(90)90053-p.

Abstract

Natural killer (NK) activities of fresh and IL-2-precultured peripheral blood mononuclear cells (PBMC) were investigated in 13 elderly subjects before and after thymopentin (TP-5) treatment and in 12 age-matched controls. The NK activity of fresh PBMC was found to be significantly higher in subjects given TP-5 at 50 mg s.c. three times per week for one month. Conversely, this type of treatment with TP-5 did not significantly modify the cytotoxic capacity of IL-2-precultured PBMC.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging / immunology
  • Cells, Cultured
  • Female
  • Humans
  • Interleukin-2 / pharmacology
  • Killer Cells, Natural / drug effects*
  • Killer Cells, Natural / physiology
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / physiology
  • Male
  • Peptide Fragments / pharmacology*
  • Randomized Controlled Trials as Topic
  • Thymopentin
  • Thymopoietins / pharmacology*
  • Thymus Hormones / pharmacology*

Substances

  • Interleukin-2
  • Peptide Fragments
  • Thymopoietins
  • Thymus Hormones
  • Thymopentin